Literature DB >> 15291742

Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line.

Gianluca Canettieri1, Antonella Franchi, Rosanna Sibilla, Ernesto Guzmán, Marco Centanni.   

Abstract

The regulation of expression of type II deiodinase (D2) is a critical mechanism to maintain appropriate intracellular concentrations of tri-iodothyronine in selected tissues. One of the major regulators of D2 concentrations is cAMP, which potently increases human type II deiodinase (hD2) gene transcription in some tissues via a conserved cAMP response element (CRE) located in the promoter region. In addition, the regulatory region of the hD2 gene contains several TATA box/transcription start site (TSS) units, suggesting the presence of different transcripts that might be characterised by different biological properties. However, it is still unclear whether one ore more TATA box/TSS units are needed in response to cAMP or to other signals able to modulate hD2 transcription. In this study we have analysed the ability of cAMP to regulate hD2 in JEG3 cells, a human choriocarcinoma cell line highly responsive to cAMP. Transient transfection assays of different hD2 gene promoter constructs revealed that cAMP induces transcription starting from the most 5' TSS, located about 80 nucleotides from the CRE. RT-PCR studies have revealed that cAMP activates the expression of a long-lived transcript in JEG3 cells. Site-directed mutagenesis and deletion analysis of promoter constructs have shown that a single CRE/TATA box/TSS unit is needed to confer responsiveness to cAMP. By using chromatin immunoprecipitation studies, we have also demonstrated that the response to cAMP involves the binding of transcription factor CRE binding protein (CREB) to the CRE located in the hD2 promoter. In summary, in JEG3 cells cAMP induces transcription of a long-lived hD2 RNA via CREB and a single CRE/TATA box/TSS unit. This study provides new insights to the regulation of expression of hD2 in placenta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291742     DOI: 10.1677/jme.0.0330051

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  8 in total

Review 1.  Functions of stem cells of thyroid glands in health and disease.

Authors:  Ebtesam A Al-Suhaimi; Khulood Al-Khater
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 2.  Deiodinases and stem cells: an intimate relationship.

Authors:  D Salvatore
Journal:  J Endocrinol Invest       Date:  2017-08-29       Impact factor: 4.256

3.  CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell line.

Authors:  Gianluca Canettieri; Maria Giulia Santaguida; Laura Antonucci; Michele Della Guardia; Antonella Franchi; Sonia Coni; Alberto Gulino; Marco Centanni
Journal:  Endocrinology       Date:  2012-06-11       Impact factor: 4.736

4.  Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.

Authors:  Wilma C G van Staveren; David Weiss Solís; Laurent Delys; David Venet; Matteo Cappello; Guy Andry; Jacques E Dumont; Frédérick Libert; Vincent Detours; Carine Maenhaut
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

5.  Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells.

Authors:  Gianluca Canettieri; Antonella Franchi; Michele Della Guardia; Ianessa Morantte; Maria Giulia Santaguida; John W Harney; P Reed Larsen; Marco Centanni
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

Review 6.  Transcriptional regulation of mammalian selenoprotein expression.

Authors:  Zoia R Stoytcheva; Marla J Berry
Journal:  Biochim Biophys Acta       Date:  2009-05-22

7.  Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph.

Authors:  Hideyuki Matsunaga; Shigekazu Sasaki; Shingo Suzuki; Akio Matsushita; Hirotoshi Nakamura; Hiroko Misawa Nakamura; Naoko Hirahara; Go Kuroda; Hiroyuki Iwaki; Kenji Ohba; Hiroshi Morita; Yutaka Oki; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

Review 8.  Similarities and Differences in the Peripheral Actions of Thyroid Hormones and Their Metabolites.

Authors:  Ruy A Louzada; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.